BrightGene Bio-Medical Technology Market Cap

BrightGene Bio-Medical Technology has a market cap or net worth of 12.37 billion as of January 8, 2025. Its market cap has decreased by -15.36% in one year.

Market Cap

12.37B

Enterprise Value

14.01B

Revenue

1.24B

Ranking

n/a

PE Ratio

65.29

Stock Price

30.20

Market Cap Chart

Since November 8, 2019, BrightGene Bio-Medical Technology's market cap has decreased from 12.55B to 12.37B, a decrease of -1.42%. That is a compound annual growth rate of -0.28%.

Market Cap History

Date	Market Cap	% Change
Jan 8, 2025	12.47B	-2.15%
Dec 31, 2024	12.75B	-13.79%
Dec 29, 2023	14.79B	55.07%
Dec 30, 2022	9.54B	-36.65%
Dec 31, 2021	15.05B	-19.85%
Dec 31, 2020	18.78B	44.16%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Shenzhen Mindray Bio-Medical Electronics	291.83B
Jiangsu Hengrui Medicine	280.03B
WuXi AppTec	149.77B
Zhangzhou Pientzehuang Pharmaceutical.,	125.62B
Aier Eye Hospital Group	116.49B
Yunnan Baiyao Group Co.,Ltd	102.74B
Shanghai United Imaging Healthcare	102.20B
Beijing Wantai Biological Pharmacy Enterprise	88.17B

Market Cap Rankings